In the United Kingdom, market sentiment is cautiously optimistic as investors digest the implications of recent political changes and economic indicators. With a new government in place and fewer businesses planning price increases, there may be subtle shifts in market dynamics that could highlight opportunities among undervalued small-cap stocks like Assura. Understanding what makes a good stock involves considering how well-positioned a company is to navigate current economic conditions, including its ability to adapt to political and economic shifts within the UK. Top 10 Undervalued Small Caps With Insider Buying In The United Kingdom Name PE PS Discount to Fair Value Value Rating Ultimate Products 9.5x 0.7x 19.85% ★★★★★☆ Norcros 7.9x 0.5x 43.59% ★★★★★☆ THG NA 0.4x 41.80% ★★★★★☆ CVS Group 21.0x 1.2x 41.78% ★★★★☆☆ M&C Saatchi NA 0.5x 49.04% ★★★★☆☆ Bytes Technology Group 28.4x 6.4x -12.42% ★★★☆☆☆ Robert Walters 20.3x 0.3x 38.84% ★★★☆☆☆ Trifast NA 0.4x -46.32% ★★★☆☆☆ GB Group NA 3.3x 19.93% ★★★☆☆☆ Hochschild Mining NA 1.8x 37.72% ★★★☆☆☆ Click here to see the full list of 33 stocks from our Undervalued Small Caps With Insider Buying screener. Underneath we present a selection of stocks filtered out by our screen. Assura Simply Wall St Value Rating: ★★★☆☆☆ Overview: Assura is a healthcare real estate investment trust that focuses on the acquisition, development, and management of primary care facilities across the UK, with a market capitalization of approximately £1.74 billion. Operations: The entity has demonstrated a consistently high gross profit margin, averaging approximately 92.4% over recent periods, with the latest figure at 90.81%. This reflects efficient cost management relative to its revenue generation, which stood at £157.8 million in the most recent reporting period. PE: -43.8x Assura, a specialist in healthcare property investment, recently showcased significant insider confidence with purchases made by executives. This move underscores a robust belief in the company's prospects amidst its strategic expansion into essential NHS infrastructure. With earnings forecasted to grow 40.91% annually and a notable reduction in net loss from GBP 119.2 million to GBP 28.8 million year-over-year, Assura's financial recovery appears well underway. The firm also announced a dividend increase and has entered into a GBP 250 million joint venture to enhance NHS community healthcare facilities, reflecting its commitment to long-term growth in this sector. Delve into the full analysis valuation report here for a deeper understanding of Assura. Examine Assura's past performance report to understand how it has performed in the past. Story Continues LSE:AGR Share price vs Value as at Jul 2024 Kier Group Simply Wall St Value Rating: ★★★☆☆☆ Overview: Kier Group is a construction and infrastructure services provider with operations primarily in building and civil engineering, supporting a market capitalization of approximately £241 million. Operations: The company generates substantial revenue from Construction and Infrastructure Services, with respective segments contributing £1.86 billion and £1.87 billion. Gross profit margin has shown variability over recent periods, trending at approximately 0.087% as of the latest reported quarter. PE: 16.7x Kier Group, often overlooked, demonstrates a compelling narrative through its financial maneuvers and strategic market positioning. Recently, insiders have shown their confidence by purchasing shares, signaling strong belief in the company's prospects. With earnings expected to grow by 22% annually, this highlights not just recovery but potential underappreciated growth avenues. Despite relying solely on external borrowing—a riskier strategy—its ability to maintain high-quality earnings amidst significant one-off items suggests resilience and adaptability in challenging environments. Dive into the specifics of Kier Group here with our thorough valuation report. Review our historical performance report to gain insights into Kier Group's's past performance.LSE:KIE Share price vs Value as at Jul 2024 MONY Group Simply Wall St Value Rating: ★★★★★★ Overview: MONY Group operates in diverse sectors including insurance, money services, travel, cashback programs, and home services, boasting a market capitalization of approximately £1.5 billion. Operations: The company generates its highest revenue from the Insurance segment at £220 million, followed by Money services which contribute £100.2 million. Gross profit margins have shown a consistent trend, with the most recent figure reported at approximately 67.67%. PE: 17.5x MONY Group, formerly known as Moneysupermarket.com, recently showcased a revenue increase to £115 million in Q1 2024 from £106 million the previous year, signaling robust operational momentum. With earnings expected to grow by over 10% annually, the company's financial health appears solid. Insider confidence is evident as they have recently purchased shares, underscoring a belief in the firm’s potential despite its reliance on external borrowing. Set to rebrand on May 20, MONY Group's evolution could further unlock value for investors looking at promising yet undervalued entities within the UK market. Click to explore a detailed breakdown of our findings in MONY Group's valuation report. Assess MONY Group's past performance with our detailed historical performance reports.LSE:MONY Share price vs Value as at Jul 2024 Taking Advantage Dive into all 33 of the Undervalued Small Caps With Insider Buying we have identified here. Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks. Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors. Ready To Venture Into Other Investment Styles? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include LSE:AGR LSE:KIE and LSE:MONY. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected] View Comments
Exploring Assura And Two Other Undervalued Small Caps With Insider Actions In The United Kingdom
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...